Targeting disrupted networks in schizophrenia: Can muscarinic drugs make a fundamental difference? [PDF]
Pratt JA, Morris BJ.
europepmc +1 more source
Associations between functional autoantibodies targeting GPCRs, antinuclear antibodies, and inflammatory cytokines TNF-α: a cross-sectional study of 19,810 individuals. [PDF]
Chen X +5 more
europepmc +1 more source
Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale. [PDF]
Mogi M +4 more
europepmc +1 more source
The dual-site agonist for human M2 muscarinic receptors Iper-8-naphtalimide induces mitochondrial dysfunction in <i>Saccharomyces cerevisiae</i>. [PDF]
Cirigliano A +11 more
europepmc +1 more source
M5 positive allosteric modulation alleviates parkinsonian motor deficits. [PDF]
Chambers NE +5 more
europepmc +1 more source
Long-Acting Muscarinic Antagonists for the Treatment of Difficult-to-Treat and Severe Asthma: A Narrative Review Focusing on Inflammation from Bench to Bedside. [PDF]
Calzetta L +6 more
europepmc +1 more source
Pharmacological and light-driven pupillary accommodation in guinea pigs: comparative effects of muscarinic modulators and illumination across developmental stages. [PDF]
Wu H +7 more
europepmc +1 more source
Comprehensive perioperative management: Prevention and treatment strategies for catheter-related bladder discomfort in urological surgery patients. [PDF]
Xu W, Sun J.
europepmc +1 more source
Long-acting β<sub>2</sub> agonist (LABA) with a long-acting muscarinic receptor antagonist (LAMA) promotes human airway smooth muscle (HASM) relaxation and circumvents β<sub>2</sub> adrenergic receptor tachyphylaxis. [PDF]
Jude J +5 more
europepmc +1 more source
Synergistic mechanisms of medullary cholinergic-serotonergic pathway interactions in regulating neuronal excitability and locomotor activities. [PDF]
Cheng Y, Dai Y, Ge R, Zhang Q.
europepmc +1 more source

